Notice and Cooperation. In the event that GSK or Theravance becomes aware of actual or threatened infringement of a Joint Patent, that Party will promptly notify the other Party in writing. In such event the matter will be handled the same as provided for GSK Patents in Section 13.2.3 and Theravance will cooperate as reasonably required by GSK in connection with such enforcement.
Appears in 6 contracts
Samples: Theravance Strategic Alliance Agreement Amendment, Governance Agreement (Theravance Inc), Theravance Strategic Alliance Agreement (Theravance Inc)